STEVE ELMS
CIK 1250195 · last filed 2026-03-09
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$18.00M
Companies
9
Total Filings
58
Lifetime Open-Market Net
$6.06M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ADMA | Director | 2,136,750 | $8.21 | $17.54M | -$17.76M | 19 | 2026-03-09 |
| MRKR | Director | 328,338 | $1.38 | $453.1K | $2.04M | 8 | 2025-11-19 |
| Elevation Oncology, Inc. (ELEV) Delisted | Director | — | $0.36 | — | $0 | 3 | 2025-07-24 |
| Zosano Pharma Corp (ZSAN) Delisted | Director | 2,740,726 | $0.56 | $1.53M | $0 | 5 | 2021-06-14 |
| Loxo Oncology, Inc. (LOXO) Delisted | Director | 5,570,102 | — | — | $18.42M | 8 | 2019-02-15 |
| PERNIX THERAPEUTICS HOLDINGS, INC. (PTX) Delisted | Director | 2,010,000 | — | — | $0 | 4 | 2016-05-31 |
| Cidara Therapeutics, Inc. (CDTX) Delisted | Director | 703,092 | $221.38 | $155.65M | $0 | 1 | 2015-04-22 |
| AMBIT BIOSCIENCES CORP (AMBI) Delisted | Director | 1,650,156 | $0.54 | $890.4K | $3.39M | 3 | 2014-09-04 |
| MAPP | Director | 0 | $27.73 | $0 | -$33.8K | 5 | 2010-05-24 |
Recent Filings · Page 3 of 6
58 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-03-18 | MRKR | Buy (P) | +1,142,857 | $2.00M | EDGAR |
| 2021-03-01 | ADMA | Grant (A) | — | $0 | EDGAR |
| 2020-06-29 | Zosano Pharma Corp (ZSAN) Delisted | Grant (A) | +7,500 | $0 | EDGAR |
| 2020-06-05 | Zosano Pharma Corp (ZSAN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-05-01 | ADMA | Grant (A) | +7,500 | $0 | EDGAR |
| 2020-03-03 | ADMA | Grant (A) | +7,500 | $0 | EDGAR |
| 2019-08-08 | MRKR | Grant (A) | — | $0 | EDGAR |
| 2019-07-18 | Zosano Pharma Corp (ZSAN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-03-15 | ADMA | Grant (A) | — | $0 | EDGAR |
| 2019-02-15 | Loxo Oncology, Inc. (LOXO) Delisted | Mixed | −2,038,920 | -$479.15M | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.